At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 336 enrolled
Drug / intervention
Influenzae vaccinedrug
Likely dose
Influenzae vaccine 0.5 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home
In Brief
A Phase 4 clinical trial evaluating Influenzae vaccine for Influenza. Completed, enrolled 336 participants across 1 site.
Detailed Summary
We hypothesize that when offered influenza vaccine at little or no cost, in a setting where the value of the vaccine is connected to one's high risk child, vaccination rates for parents will approach 90-95%, similar to rates obtained in the Neonatal Intensive Care Unit environment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2008
First PostedDec 2008
Primary CompletionSep 2009
TodayJul 2026
First PostedDec 19, 2008
Enrollment StartDec 1, 2008
Primary CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 17.5 years ago
Interventions
Influenzae vaccinedrug
0.5 mL Deltoid Intramuscular Injection X 1